Harmony Biosciences Holdings, Inc. (HRMY) operating margin
Harmony Biosciences Holdings, Inc. (HRMY) had an operating margin of 24.0% in fiscal 2025 (the year ended December 31, 2025). That is 2.7 percentage points lower than the 26.7% of fiscal 2024. Figures as of 18 Nov 2026, 12:28 UTC, from the company's filings with the SEC and Yahoo Finance.
Key facts
- Operating margin, fiscal 2025
- 24.0%
- Change on fiscal 2024
- −2.7 pts
- Highest on record
- 33.0%fiscal 2023
- Lowest on record
- -2433.8%fiscal 2019
- Fiscal years on record
- 72019–2025
Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.
Harmony Biosciences Holdings, Inc. operating margin, in more detail
Across the 7 fiscal years on record (2019–2025), the highest was 33.0% in fiscal 2023 and the lowest -2433.8% in fiscal 2019. The fiscal 2025 figure is higher than in 33% of the 6 earlier fiscal years on record, whose median is 27.1%.
Gross margin was 77.2% in fiscal 2025. Net margin was 18.3% in fiscal 2025.
Operating margin by fiscal year
- Operating margin
- Gross margin
- Net margin
Harmony Biosciences Holdings, Inc. operating margin, year by year
| Fiscal year | Operating margin | Change | Year ended | Gross margin | Net margin |
|---|---|---|---|---|---|
| 2025 | 24.0% | 2.7 pts down | 77.2% | 18.3% | |
| 2024 | 26.7% | 6.3 pts down | 78.1% | 20.4% | |
| 2023 | 33.0% | 5.5 pts up | 79.2% | 22.1% | |
| 2022 | 27.4% | 1.2 pts down | 80.9% | 41.4% | |
| 2021 | 28.7% | 18.0 pts up | 81.8% | 11.3% | |
| 2020 | 10.6% | 2444.4 pts up | 82.6% | -23.1% | |
| 2019 | -2433.8% | — | 73.7% | -2535.1% |
Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.
How it is calculated
Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.
How to read it
It shows how much of each unit of sales survives the cost of running the business — rising margins point to pricing power or scale, falling ones to pressure.
Harmony Biosciences Holdings, Inc., figure by figure
- Harmony Biosciences Holdings, Inc. market cap
- Harmony Biosciences Holdings, Inc. revenue
- Harmony Biosciences Holdings, Inc. earnings
- Harmony Biosciences Holdings, Inc. earnings per share (EPS)
- Harmony Biosciences Holdings, Inc. P/E ratio
- Harmony Biosciences Holdings, Inc. P/S ratio
- Harmony Biosciences Holdings, Inc. P/B ratio
- Harmony Biosciences Holdings, Inc. free cash flow
- Harmony Biosciences Holdings, Inc. dividend
- Harmony Biosciences Holdings, Inc. shares outstanding
- Harmony Biosciences Holdings, Inc. total debt
- Harmony Biosciences Holdings, Inc. cash on hand
- Harmony Biosciences Holdings, Inc. total assets
- Harmony Biosciences Holdings, Inc. return on equity (ROE)
- Harmony Biosciences Holdings, Inc. return on invested capital (ROIC)
Harmony Biosciences Holdings, Inc. (HRMY) overview: price, valuation and scorecard
Harmony Biosciences Holdings, Inc. operating margin: questions and answers
What is Harmony Biosciences Holdings, Inc.'s operating margin?
Harmony Biosciences Holdings, Inc. (HRMY) had an operating margin of 24.0% in fiscal 2025 (the year ended December 31, 2025). That is 2.7 percentage points lower than the 26.7% of fiscal 2024.
Is Harmony Biosciences Holdings, Inc.'s operating margin high or low compared with its own history?
The fiscal 2025 figure is higher than in 33% of the 6 earlier fiscal years on record, whose median is 27.1%.
What are the highest and lowest operating margin figures on record for Harmony Biosciences Holdings, Inc.?
Across the 7 fiscal years on record (2019–2025), the highest was 33.0% in fiscal 2023 and the lowest -2433.8% in fiscal 2019.
What are Harmony Biosciences Holdings, Inc.'s gross and net margins?
Gross margin was 77.2% in fiscal 2025. Net margin was 18.3% in fiscal 2025.
How is Harmony Biosciences Holdings, Inc.'s operating margin calculated?
Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income. For Harmony Biosciences Holdings, Inc. it is on record here for 7 fiscal years, 2019 to 2025.
Fiscal years are named for the calendar year they end in.
Learn: operating margin
All stocks guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
Cite this page
Funkfolio, “Harmony Biosciences Holdings, Inc. (HRMY) operating margin”, data as of 18 November 2026. https://funkfolio.com/stock/HRMY/operating-margin
Underlying data: the company's filings with the SEC and Yahoo Finance.